Literature DB >> 21967975

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Stefan O Ciurea1, Peter F Thall, Xuemei Wang, Sa A Wang, Ying Hu, Pedro Cano, Fleur Aung, Gabriela Rondon, Jeffrey J Molldrem, Martin Korbling, Elizabeth J Shpall, Marcos de Lima, Richard E Champlin, Marcelo Fernandez-Vina.   

Abstract

Anti-HLA donor-specific Abs (DSAs) have been reported to be associated with graft failure in mismatched hematopoietic stem cell transplantation; however, their role in the development of graft failure in matched unrelated donor (MUD) transplantation remains unclear. We hypothesize that DSAs against a mismatched HLA-DPB1 locus is associated with graft failure in this setting. The presence of anti-HLA Abs before transplantation was determined prospectively in 592 MUD transplantation recipients using mixed-screen beads in a solid-phase fluorescent assay. DSA identification was performed using single-Ag beads containing the corresponding donor's HLA-mismatched Ags. Anti-HLA Abs were detected in 116 patients (19.6%), including 20 patients (3.4%) with anti-DPB1 Abs. Overall, graft failure occurred in 19 of 592 patients (3.2%), including 16 of 584 (2.7%) patients without anti-HLA Abs compared with 3 of 8 (37.5%) patients with DSA (P = .0014). In multivariate analysis, DSAs were the only factor highly associated with graft failure (P = .0001; odds ratio = 21.3). Anti-HLA allosensitization was higher overall in women than in men (30.8% vs 12.1%; P < .0001) and higher in women with 1 (P = .008) and 2 or more pregnancies (P = .0003) than in men. We conclude that the presence of anti-DPB1 DSAs is associated with graft failure in MUD hematopoietic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21967975      PMCID: PMC3761379          DOI: 10.1182/blood-2011-06-362111

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.

Authors:  Carolyn Katovich Hurley; Lee Ann Baxter Lowe; Brent Logan; Chatchada Karanes; Claudio Anasetti; Daniel Weisdorf; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2003-10       Impact factor: 5.742

2.  The role of anti-HLA antibodies in heart transplantation.

Authors:  N Suciu-Foca; E Reed; C Marboe; P Harris; P X Yu; Y K Sun; E Ho; E Rose; K Reemtsma; D W King
Journal:  Transplantation       Date:  1991-03       Impact factor: 4.939

3.  New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans.

Authors:  W Klitz; M Maiers; S Spellman; L A Baxter-Lowe; B Schmeckpeper; T M Williams; M Fernandez-Viña
Journal:  Tissue Antigens       Date:  2003-10

4.  The impact of anti-HLA antibodies on unrelated cord blood transplantations.

Authors:  Minoko Takanashi; Yoshiko Atsuta; Koki Fujiwara; Hideki Kodo; Shunro Kai; Hiroyuki Sato; Masatoshi Kohsaki; Hiroshi Azuma; Hidenori Tanaka; Atsuko Ogawa; Kazunori Nakajima; Shunichi Kato
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

5.  Significance of the positive crossmatch test in kidney transplantation.

Authors:  R Patel; P I Terasaki
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

6.  Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations.

Authors:  A B Begovich; P V Moonsamy; S J Mack; L F Barcellos; L L Steiner; S Grams; V Suraj-Baker; J Hollenbach; E Trachtenberg; L Louie; P Zimmerman; A V Hill; M Stoneking; T Sasazuki; V I Konenkov; M L Sartakova; V P Titanji; O Rickards; W Klitz
Journal:  Tissue Antigens       Date:  2001-05

7.  Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.

Authors:  S M Davies; C Kollman; C Anasetti; J H Antin; J Gajewski; J T Casper; A Nademanee; H Noreen; R King; D Confer; N A Kernan
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

8.  Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.

Authors:  Daniel J Weisdorf; Claudio Anasetti; Joseph H Antin; Nancy A Kernan; Craig Kollman; David Snyder; Effie Petersdorf; Gene Nelson; Philip McGlave
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

9.  Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

Authors:  Michael G Kiehl; Ludwig Kraut; Rainer Schwerdtfeger; Bernd Hertenstein; Mats Remberger; Nicolaus Kroeger; Mathias Stelljes; Martin Bornhaeuser; Hans Martin; Christoph Scheid; Arnold Ganser; Axel R Zander; Joachim Kienast; Gerhard Ehninger; Dieter Hoelzer; Volker Diehl; Axel A Fauser; Olle Ringden
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

10.  Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

Authors:  Rui Pei; Jar-How Lee; Neng-Jen Shih; Mike Chen; Paul I Terasaki
Journal:  Transplantation       Date:  2003-01-15       Impact factor: 4.939

View more
  62 in total

1.  Post-transplantation-emerging anti-HLA DQA1/DQB1 antibody possibly responsible for graft rejection after myeloablative-unrelated marrow grafting.

Authors:  H Yabe; T Morimoto; H Takakura; M Okuya; R Ikegaya; S Kato; T Sugimoto; F Tsuchida; M Murakami; H Mochizuki; M Yabe
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

3.  Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation.

Authors:  J Zou; R Romee; M Slade; D Phelan; J Keller; T Mohanakumar; B J Grossman
Journal:  Bone Marrow Transplant       Date:  2017-02-20       Impact factor: 5.483

4.  Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation.

Authors:  Ross M Fasano; Ewelina Mamcarz; Sharon Adams; Theresa Donohue Jerussi; Kyoko Sugimoto; Xin Tian; Willy A Flegel; Richard W Childs
Journal:  Br J Haematol       Date:  2014-04-18       Impact factor: 6.998

5.  The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection.

Authors:  A L Dias; S Hashmi; W Hogan; N Baig; L Wakefield; J Kreuter; M J Gandhi
Journal:  Bone Marrow Transplant       Date:  2017-02-20       Impact factor: 5.483

6.  Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.

Authors:  R Hanajiri; M Murata; K Sugimoto; M Murase; R Sakemura; T Goto; K Watanabe; N Imahashi; S Terakura; H Ohashi; Y Akatsuka; S Kurahashi; K Miyamura; H Kiyoi; T Nishida; T Naoe
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

7.  The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

Authors:  Carolyn Katovich Hurley; Ann Woolfrey; Tao Wang; Michael Haagenson; John Umejiego; Mahmoud Aljurf; Medhat Askar; Minoo Battiwalla; Jason Dehn; John Horan; Machteld Oudshoorn; Joseph Pidala; Wael Saber; Victoria Turner; Stephanie J Lee; Stephen R Spellman
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

8.  Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies.

Authors:  H-L Liu; Z-M Sun; L-Q Geng; X-B Wang; K-Y Ding; J Tong; B-L Tang; C-Y Zhou; W Yao; C-C Zheng; K-D Song; X-Y Zhu; W Wei; Y Wang
Journal:  Bone Marrow Transplant       Date:  2014-05-19       Impact factor: 5.483

9.  A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

Authors:  U Gergis; S Mayer; B Gordon; T Mark; R Pearse; T Shore; K Van Besien
Journal:  Bone Marrow Transplant       Date:  2014-02-17       Impact factor: 5.483

10.  Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.

Authors:  Parastoo B Dahi; Jonathan Barone; Sean M Devlin; Courtney Byam; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Susan H Hsu; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-23       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.